Clinical Features and Vitreous Biomarkers of Early-Onset Type 2 Diabetes Mellitus Complicated with Proliferative Diabetic Retinopathy

References

• Huo X, Gao L, Guo L, et al. Risk of non-fatal cardiovascular diseases in early-onset versus late-onset type 2 diabetes in China: a cross-sectional study. Lancet Diabetes Endocrinol. 2016;4(2):115–124. doi:10.1016/S2213-8587(15)00508-2
   PubMed Web of Science ®Google Scholar
• Wong J, Molyneaux L, Constantino M, Twigg SM, Yue DK. Timing is everything: age of onset influences long-term retinopathy risk in type 2 diabetes, independent of traditional risk factors. Diabetes Care. 2008;31(10):1985–1990. doi:10.2337/dc08-0580
   PubMed Web of Science ®Google Scholar
• Wang Y, Lin Z, Zhai G, et al. Prevalence of and risk factors for diabetic retinopathy and diabetic macular edema in patients with early and late onset diabetes mellitus. Ophthalmic Res. 2020. doi:10.1159/000508335
   Web of Science ®Google Scholar
• Liu JJ, Liu S, Gurung RL, et al. Risk of progressive chronic kidney disease in individuals with early-onset type 2 diabetes: a prospective cohort study. Nephrol Dial Transplant. 2020;35(1):115–121. doi:10.1093/ndt/gfy211
   Web of Science ®Google Scholar
• Zheng L, Chen X, Luo T, et al. Early-onset type 2 diabetes as a risk factor for end-stage renal disease in patients with diabetic kidney disease. Prev Chronic Dis. 2020;17:E50. doi:10.5888/pcd17.200076
   PubMed Web of Science ®Google Scholar
• Capitao M, Soares R. Angiogenesis and inflammation crosstalk in diabetic retinopathy. J Cell Biochem. 2016;117(11):2443–2453. doi:10.1002/jcb.25575
   PubMed Web of Science ®Google Scholar
• Forrester JV, Kuffova L, Delibegovic M. The role of inflammation in diabetic retinopathy. Front Immunol. 2020;11:583687. doi:10.3389/fimmu.2020.583687
   PubMed Web of Science ®Google Scholar
• Suzuki Y, Suzuki K, Kudo T, Metoki T, Nakazawa M. Level of vascular endothelial growth factor in the vitreous fluid of proliferative diabetic retinopathy patients and prognosis after vitrectomy. Ophthalmologica. 2016;236(3):133–138. doi:10.1159/000449261
   Web of Science ®Google Scholar
• Tsai T, Kuehn S, Tsiampalis N, et al. Anti-inflammatory cytokine and angiogenic factors levels in vitreous samples of diabetic retinopathy patients. PLoS One. 2018;13(3):e0194603. doi:10.1371/journal.pone.0194603
   PubMed Web of Science ®Google Scholar
• Sun C, Zhang H, Jiang J, et al. Angiogenic and inflammatory biomarker levels in aqueous humor and vitreous of neovascular glaucoma and proliferative diabetic retinopathy. Int Ophthalmol. 2020;40(2):467–475. doi:10.1007/s10792-019-01207-4
   PubMed Web of Science ®Google Scholar
• Lei J, Ding G, Xie A, et al. Aqueous humor monocyte chemoattractant protein-1 predicted long-term visual outcome of proliferative diabetic retinopathy undergone intravitreal injection of bevacizumab and vitrectomy. PLoS One. 2021;16(3):e0248235. doi:10.1371/journal.pone.0248235
   Web of Science ®Google Scholar
• Wu F, Phone A, Lamy R, et al. Correlation of aqueous, vitreous, and plasma cytokine levels in patients with proliferative diabetic retinopathy. Invest Ophthalmol Vis Sci. 2020;61(2):26. doi:10.1167/iovs.61.2.26
   Web of Science ®Google Scholar
• Nawaz IM, Rezzola S, Cancarini A, et al. Human vitreous in proliferative diabetic retinopathy: characterization and translational implications. Prog Retin Eye Res. 2019;72:100756. doi:10.1016/j.preteyeres.2019.03.002
   PubMed Web of Science ®Google Scholar
• Yeung RO, Zhang Y, Luk A, et al. Metabolic profiles and treatment gaps in young-onset type 2 diabetes in Asia (the jade programme): a cross-sectional study of a prospective cohort. Lancet Diabetes Endocrinol. 2014;2(12):935–943. doi:10.1016/S2213-8587(14)70137-8
   Web of Science ®Google Scholar
• Kong X, Xing X, Zhang X, Hong J, Yang W. Early-onset type 2 diabetes is associated with genetic variants of beta-cell function in the Chinese han population. Diabetes Metab Res Rev. 2020;36(2):e3214. doi:10.1002/dmrr.3214
   Web of Science ®Google Scholar
• Song SH, Gray TA. Early-onset type 2 diabetes: high risk for premature diabetic retinopathy. Diabetes Res Clin Pract. 2011;94(2):207–211. doi:10.1016/j.diabres.2011.07.030
   PubMed Web of Science ®Google Scholar
• Pan J, Jia W. Early-onset diabetes: an epidemic in China. Front Med. 2018;12(6):624–633. doi:10.1007/s11684-018-0669-1
   PubMed Web of Science ®Google Scholar
• Yuan J, Zhang L, Jia P, Xin Z, Yang JK. Early onset age increased the risk of diabetic retinopathy in type 2 diabetes patients with duration of 10–20 years and hba1c >/=7%: a hospital-based case-control study. Int J Endocrinol. 2021;2021:5539654. doi:10.1155/2021/5539654
   Web of Science ®Google Scholar
• Okudaira M, Yokoyama H, Otani T, Uchigata Y, Iwamoto Y. Slightly elevated blood pressure as well as poor metabolic control are risk factors for the progression of retinopathy in early-onset Japanese type 2 diabetes. J Diabetes Complications. 2000;14(5):281–287. doi:10.1016/S1056-8727(00)00114-8
   Web of Science ®Google Scholar
• Kovacs K, Marra KV, Yu G, et al. Angiogenic and inflammatory vitreous biomarkers associated with increasing levels of retinal ischemia. Invest Ophthalmol Vis Sci. 2015;56(11):6523–6530. doi:10.1167/iovs.15-16793
   PubMed Web of Science ®Google Scholar
• Yoshida S, Kubo Y, Kobayashi Y, et al. Increased vitreous concentrations of mcp-1 and il-6 after vitrectomy in patients with proliferative diabetic retinopathy: possible association with postoperative macular oedema. Br J Ophthalmol. 2015;99(7):960–966. doi:10.1136/bjophthalmol-2014-306366
   PubMed Web of Science ®Google Scholar
• Deshmane SL, Kremlev S, Amini S, Sawaya BE. Monocyte chemoattractant protein-1 (mcp-1): an overview. J Interferon Cytokine Res. 2009;29(6):313–326. doi:10.1089/jir.2008.0027
   PubMed Web of Science ®Google Scholar
• Cohen T, Nahari D, Cerem LW, Neufeld G, Levi BZ. Interleukin 6 induces the expression of vascular endothelial growth factor. J Biol Chem. 1996;271(2):736–741. doi:10.1074/jbc.271.2.736
   PubMed Web of Science ®Google Scholar
• Koskela UE, Kuusisto SM, Nissinen AE, Savolainen MJ, Liinamaa MJ. High vitreous concentration of il-6 and il-8, but not of adhesion molecules in relation to plasma concentrations in proliferative diabetic retinopathy. Ophthalmic Res. 2013;49(2):108–114. doi:10.1159/000342977
   Web of Science ®Google Scholar
• Ghasemi H, Ghazanfari T, Yaraee R, Faghihzadeh S, Hassan ZM. Roles of il-8 in ocular inflammations: a review. Ocul Immunol Inflamm. 2011;19(6):401–412. doi:10.3109/09273948.2011.618902
   PubMed Web of Science ®Google Scholar
• Yoshida S, Kobayashi Y, Nakao S, et al. Differential association of elevated inflammatory cytokines with postoperative fibrous proliferation and neovascularization after unsuccessful vitrectomy in eyes with proliferative diabetic retinopathy. Clin Ophthalmol. 2017;11:1697–1705. doi:10.2147/OPTH.S141821
   PubMed Web of Science ®Google Scholar
• Cvitkovic K, Sesar A, Sesar I, et al. Concentrations of selected cytokines and vascular endothelial growth factor in aqueous humor and serum of diabetic patients. Semin Ophthalmol. 2020;35(2):126–133. doi:10.1080/08820538.2020.1755320
   PubMed Web of Science ®Google Scholar
• Abu El-Asrar AM, Struyf S, Kangave D, Geboes K, Van Damme J. Chemokines in proliferative diabetic retinopathy and proliferative vitreoretinopathy. Eur Cytokine Netw. 2006;17(3):155–165.
   Web of Science ®Google Scholar
• Yoshida S, Yoshida A, Ishibashi T, Elner SG, Elner VM. Role of mcp-1 and mip-1alpha in retinal neovascularization during postischemic inflammation in a mouse model of retinal neovascularization. J Leukoc Biol. 2003;73(1):137–144. doi:10.1189/jlb.0302117
   Web of Science ®Google Scholar
• Wynn TA. Cellular and molecular mechanisms of fibrosis. J Pathol. 2008;214(2):199–210. doi:10.1002/path.2277
   PubMed Web of Science ®Google Scholar
• Romagnani P, Lasagni L, Annunziato F, Serio M, Romagnani S. Cxc chemokines: the regulatory link between inflammation and angiogenesis. Trends Immunol. 2004;25(4):201–209. doi:10.1016/j.it.2004.02.006
   PubMed Web of Science ®Google Scholar
• Altun A, Kanar HS, Aki SF, Arsan A, Hacisalihoglu A. Effectiveness and safety of coadministration of intravitreal dexamethasone implant and silicone oil endotamponade for proliferative diabetic retinopathy with tractional diabetic macular edema. J Ocul Pharmacol Ther. 2021;37(2):131–137. doi:10.1089/jop.2020.0079
   Web of Science ®Google Scholar
• Lv X, Ran X, Chen X, et al. Early-onset type 2 diabetes: a high-risk factor for proliferative diabetic retinopathy (pdr) in patients with microalbuminuria. Medicine. 2020;99(19):e20189. doi:10.1097/MD.0000000000020189
   Web of Science ®Google Scholar
• Harris nwanyanwu K, Talwar N, Gardner TW, et al. Predicting development of proliferative diabetic retinopathy. Diabetes Care. 2013;36(6):1562–1568. doi:10.2337/dc12-0790
   Web of Science ®Google Scholar
• Mitchell SL, Neininger AC, Bruce CN, et al. Mitochondrial haplogroups modify the effect of diabetes duration and hba1c on proliferative diabetic retinopathy risk in patients with type 2 diabetes. Invest Ophthalmol Vis Sci. 2017;58(14):6481–6488. doi:10.1167/iovs.17-22804
   Web of Science ®Google Scholar
• Hainsworth DP, Bebu I, Aiello LP, et al. Risk factors for retinopathy in type 1 diabetes: the DCCT/EDIC study. Diabetes Care. 2019;42(5):875–882. doi:10.2337/dc18-2308
   PubMed Web of Science ®Google Scholar
• Lind M, Pivodic A, Svensson AM, et al. Hba1c level as a risk factor for retinopathy and nephropathy in children and adults with type 1 diabetes: Swedish population based cohort study. BMJ. 2019;366:l4894. doi:10.1136/bmj.l4894
   Web of Science ®Google Scholar
• Tokarz A, Konkolewska M, Kusnierz-Cabala B, et al. Retinopathy severity correlates with rantes concentrations and CCR 5-positive microvesicles in diabetes. Folia Med Cracov. 2019;59(3):95–112.doi:10.24425/fmc.2019.131139
   PubMedGoogle Scholar
• Chernykh VV, Varvarinsky EV, Smirnov EV, Chernykh DV, Trunov AN. Proliferative and inflammatory factors in the vitreous of patients with proliferative diabetic retinopathy. Indian J Ophthalmol. 2015;63(1):33–36. doi:10.4103/0301-4738.151464
   PubMed Web of Science ®Google Scholar
• Zeng Y, Cao D, Yu H, et al. Comprehensive analysis of vitreous humor chemokines in type 2 diabetic patients with and without diabetic retinopathy. Acta Diabetol. 2019;56(7):797–805. doi:10.1007/s00592-019-01317-6
   Web of Science ®Google Scholar
• Cao YL, Zhang FQ, Hao FQ. Th1/th2 cytokine expression in diabetic retinopathy. Genet Mol Res. 2016;15(3). doi:10.4238/gmr.15037311
   Web of Science ®Google Scholar